Blackstone Life Sciences
North America, Massachusetts, United States, Cambridge
Description
Blackstone Life Sciences is a private equity segment of The Blackstone Group.
Investor Profile
Blackstone Life Sciences has backed more than 17 startups, with 2 new investments in the last 12 months alone. The firm has led 10 rounds, about 59% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States, France.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
- Led 1 rounds in the past year.
Stage Focus
- Post Ipo Equity (47%)
- Series C (18%)
- Series B (12%)
- Series A (12%)
- Post Ipo Debt (6%)
- Series D (6%)
Country Focus
- United States (94%)
- France (6%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Biopharma
- Life Science
- Precision Medicine
- Health Diagnostics
- Alternative Medicine
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Blackstone Life Sciences frequently co-invest with?
What are some of recent deals done by Blackstone Life Sciences?
Find More Investors Like Blackstone Life Sciences
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
